AGN-95763-82926
3 vaccinations
2 coded responses
29 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 992 / WA
- Registered
- 2021-01-22
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-22
Registered in v-safe
-
2021-01-22
Dose 1 — Pfizer-BioNTech
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-01-30
- 2021-02-07
-
2021-02-12
Dose 2 — Pfizer-BioNTech
- 2021-02-12
-
2021-02-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-26
- 2021-03-06
- 2021-03-12
- 2021-03-19
- 2021-03-26
-
2021-05-14
Survey response — 3 months, dose 2MedDRA: Cough, Fatigue, Headache, Lacrimation increased, Lymph node pain, Lymphadenopathy, Nasal congestion, Nasopharyngitis, Oropharyngeal pain, Rhinorrhoea — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Cold virus (presumably). Cough, sore throat, stuffy/runny nose, watery eyes, swollen/tender lymph nodes, headache, fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-13
-
2022-01-14
Dose 3 — Pfizer-BioNTech
- 2022-02-14
- 2022-02-14
- 2022-02-18
- 2022-02-26
- 2022-07-17
-
2023-01-14
Survey response — 12 months, dose 3MedDRA: Abortion spontaneous, Depressive symptom — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-14
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-01-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-22 | Pfizer-BioNTech | |
| 2 | 2021-02-12 | Pfizer-BioNTech | |
| 3 | 2022-01-14 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-01-14 | Unsuccessful |
Free text
Release 8 — 3 months, dose 2
Symptoms: Cold virus (presumably). Cough, sore throat, stuffy/runny nose, watery eyes, swollen/tender lymph nodes, headache, fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Depressive symptom | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Lacrimation increased | ✓ | ✓ | ✓ |
| SD | Lymph node pain | ✓ | ✓ | ✓ |
| SD | Lymphadenopathy | ✓ | ✓ | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release